Balyasny Asset Management »

Galectin Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $90k 22k 4.16

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Galectin Therapeutics

Vanguard Group
Vanguard Capital Management
Advisor Group Holdings
Susquehanna International
Dr. Jeffrey R. Jay, M.D.
BlackRock
Millennium Management
Sontag Advisory
Geode Capital Management
Marshall Wace
Two Sigma Investments
Commonwealth Equity Services
Citadel Advisors
Jane Street
Vanguard Fiduciary Trust

View all funds holding Galectin Therapeutics